论文部分内容阅读
目的 探讨普通血液透析、CRRT治疗终末期心力衰竭的临床价值。方法我院2007年4月~2009年8月收治40例终末期心力衰竭患者被随机分为两组,普通血液透析组22例,CRRT组18例,两组患者治疗前后监测血气分析、血生化、尿量;治疗1周后、1个月后评价临床症状、心功能改善情况。结果普通血液透析与CRRT治疗终末期心力衰竭均有效,对血液动力学不稳定患者CRRT优于普通血液透析。结论血液净化是治疗终末期心力衰竭的有效方法,能较快改善心肺功能、维持水电解质酸碱平衡、提高患者生存质量。
Objective To investigate the clinical value of routine hemodialysis and CRRT in the treatment of end-stage heart failure. Methods Forty patients with end-stage heart failure who were admitted to our hospital from April 2007 to August 2009 were randomly divided into two groups: 22 patients in general hemodialysis group and 18 patients in CRRT group. Blood gas analysis, blood biochemical analysis , Urine output; 1 week after treatment, 1 month after the evaluation of clinical symptoms, cardiac function improved. Results Both routine hemodialysis and CRRT were effective in treating end-stage heart failure. CRRT was superior to routine hemodialysis in hemodynamic unstable patients. Conclusion Blood purification is an effective method for the treatment of end-stage heart failure. It can quickly improve cardiopulmonary function, maintain the acid-base balance of water and electrolyte, and improve the quality of life of patients.